ArticleCureus2026

Durable Response to Sotorasib Plus Panitumumab in NRAS G12C-Mutated, Microsatellite Instability-High (MSI-H) Rectal Cancer Refractory to Immunotherapy.

Latif Karahan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.